Source: ExploreBit

Sprim Als: Prota Therapeutics Raises USD 21M Equity and Debt Financing

Prota Therapeutics Melbourne Australia based biotechnology company focused raises USD 21M equity and debt funding The round led by SPRIM Global Investments

Read full article »
Sprim Als's Competitors | Sprim Als's News | Sprim Als's Financials
Stay up-to-date with the latest news on Sprim Als
Est. Annual Revenue
$100K-5.0M
Est. Employees
250-500
Michael Shleifer's photo - Managing Partner of Sprim Als

Managing Partner

Michael Shleifer

CEO Approval Rating

72/100

Read more
Stay up-to-date with the latest news on Sprim Als